Insider Trading & Ownership - HANNAH ALISON L.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for HANNAH ALISON L.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-07-20
Sale
2022-07-21
4:09 pm
CytomX Therapeutics Inc.CTMXHANNAH ALISON L.
Chief Medical Officer
5,602$1.4219$7,96531,898
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-08-10
Exercise
2024-08-13
4:24 pm
2024-08-10
N/A
NEOGENOMICS INCNEOHANNAH ALISON L.
Director
11,336$0176,378
(Direct)
View
2024-06-01
Option Award
2024-06-04
4:07 pm
2025-06-01
2034-06-01
NEOGENOMICS INCNEOHANNAH ALISON L.
Director
20,926$0176,378
(Direct)
View
2024-05-25
Option Award
2024-05-29
7:20 pm
N/A
2034-05-25
RIGEL PHARMACEUTICALS INCRIGLHANNAH ALISON L.
Director
55,000$0111,250
(Direct)
View
2023-08-10
Option Award
2023-08-14
5:41 pm
2024-08-10
2033-08-10
NEOGENOMICS INCNEOHANNAH ALISON L.
Director
19,689$0155,452
(Direct)
View
2023-05-26
Option Award
2023-07-12
6:45 pm
N/A
2033-05-26
RIGEL PHARMACEUTICALS INCRIGLHANNAH ALISON L.
Director
55,000$086,250
(Direct)
View
2022-07-19
Option Award
2022-07-21
4:09 pm
N/A
N/A
CytomX Therapeutics Inc.CTMXHANNAH ALISON L.
Chief Medical Officer
15,000$031,898
(Direct)
View
2022-06-10
Option Award
2022-06-14
8:42 pm
2023-06-10
2029-06-10
NEOGENOMICS INCNEOHANNAH ALISON L.
Director
29,438$0135,763
(Direct)
View
2022-05-20
Option Award
2022-05-23
5:50 pm
N/A
2032-05-20
RIGEL PHARMACEUTICALS INCRIGLHANNAH ALISON L.
Director
55,000$061,250
(Direct)
View
2022-02-02
Option Award
2022-02-04
4:51 pm
N/A
2032-02-01
CytomX Therapeutics Inc.CTMXHANNAH ALISON L.
Chief Medical Officer
157,500$0157,500
(Direct)
View
2021-10-24
Option Award
2021-10-26
4:24 pm
N/A
2031-10-23
CytomX Therapeutics Inc.CTMXHANNAH ALISON L.
Chief Medical Officer
70,000$070,000
(Direct)
View
2021-06-02
Option Award
2021-06-04
8:00 pm
2022-06-02
2028-06-02
NEOGENOMICS INCNEOHANNAH ALISON L.
Director
6,795$0106,325
(Direct)
View
2021-05-19
Option Award
2021-05-21
9:11 pm
N/A
2031-05-19
RIGEL PHARMACEUTICALS INCRIGLHANNAH ALISON L.
Director
13,750$013,750
(Direct)
View
2021-05-14
Option Award
2021-05-18
7:01 pm
N/A
2031-05-14
RIGEL PHARMACEUTICALS INCRIGLHANNAH ALISON L.
Director
80,000$080,000
(Direct)
View
2021-02-26
Option Award
2021-03-02
5:00 pm
N/A
2031-02-25
CytomX Therapeutics Inc.CTMXHANNAH ALISON L.
Chief Medical Officer
175,000$0175,000
(Direct)
View
2020-08-06
Exercise
2020-08-10
6:22 pm
N/A
N/A
NEOGENOMICS INCNEOHANNAH ALISON L.
Director
10,000$7.2799,530
(Direct)
View
2020-08-06
Exercise
2020-08-10
6:22 pm
N/A
2022-05-25
NEOGENOMICS INCNEOHANNAH ALISON L.
Director
10,000$099,530
(Direct)
View
2020-05-28
Option Award
2020-06-01
7:38 pm
2021-05-28
2027-05-28
NEOGENOMICS INCNEOHANNAH ALISON L.
Director
6,146$099,530
(Direct)
View
2020-02-03
Option Award
2020-02-05
3:44 pm
N/A
2030-02-02
CytomX Therapeutics Inc.CTMXHANNAH ALISON L.
Chief Medical Officer
250,000$0250,000
(Direct)
View